almagate has been researched along with indocyanine green in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apte, RS; Blinder, KJ; Dhalla, MS; Hariprasad, SM; Tewari, A | 1 |
| Adamis, AP; Chakravarthy, U; Cunningham, ET; Goldbaum, M; Guyer, DR; Katz, B; Patel, M | 1 |
| Dietzel, M; Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G | 1 |
| Kurihara, T; Nagai, N; Okamoto, T; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
1 trial(s) available for almagate and indocyanine green
| Article | Year |
|---|---|
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Aptamers, Nucleotide; Choroidal Neovascularization; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2006 |
3 other study(ies) available for almagate and indocyanine green
| Article | Year |
|---|---|
Retinal pigment epithelial tear following intravitreal pegaptanib sodium.
Topics: Aged; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Pigment Epithelium of Eye; Retinal Detachment; Retinal Perforations; Tomography, Optical Coherence; Visual Acuity | 2006 |
[Retinal angiomatous proliferation with associated pigment epithelium detachment: anti-VEGF therapy].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Ophthalmoscopes; Ranibizumab; Retina; Retinal Detachment; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
Topics: Aged; Aptamers, Nucleotide; Basement Membrane; Coloring Agents; Epiretinal Membrane; Fluorescein Angiography; Humans; Indocyanine Green; Intraoperative Period; Male; Retinal Perforations; Vascular Endothelial Growth Factor A; Vitrectomy; Wet Macular Degeneration | 2014 |